<--- Back to Details
First PageDocument Content
Peptide hormones / Thyroid / Liraglutide / Anti-diabetic medication / Metformin / Medullary thyroid cancer / Novo Nordisk / Rosiglitazone / Sulfonylurea / Diabetes management / Calcitonin / Glimepiride
Date: 2010-01-26 07:06:39
Peptide hormones
Thyroid
Liraglutide
Anti-diabetic medication
Metformin
Medullary thyroid cancer
Novo Nordisk
Rosiglitazone
Sulfonylurea
Diabetes management
Calcitonin
Glimepiride

Victoza (liraglutide [rDNA origin] injection

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 273,22 KB

Share Document on Facebook

Similar Documents

Recall: Riomet™ (Metformin Hydrochloride Oral Solution): Microbial Contamination At PharmPix we are committed to the health and well-being of patients. It is for this reason that we inform that on November 27, 2017 the

DocID: 1vpXt - View Document

Microsoft Word - ALOGLIPTIN AND METFORMIN TABLETS_ALK334_R3_PI_CLEAN_12_5-500MG_12_5MG-1000MG_13June2016 .doc

DocID: 1tj6K - View Document

Microsoft Word - ALOGLIPTIN AND METFORMIN TABLETS_ALK334_R3_PI_CLEAN_12_5-500MG_12_5MG-1000MG_13June2016 .doc

DocID: 1tcHG - View Document

FDA Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function

DocID: 1t6MV - View Document

Biguanides / Guanidines / Metformin / RTT / Renal function / Medicine / Clinical medicine / Chemistry

Schweizerische Gesellschaft für Endokrinologie und Diabetologie Société Suisse d’Endocrinologie et de Diabétologie Società Svizzera d’Endocrinologia e Diabetologia Societad Svizra d’Endocrinologia e Diabetolog

DocID: 1qXHV - View Document